IMGN | ImmunoGen (NASDAQ:IMGN) Price Target Increased to $6.00 by Analysts at SVB Leerink

ImmunoGen (NASDAQ:IMGN) had its target price hoisted by SVB Leerink from $5.00 to $6.00 in a research note released on Friday morning, reports.The brokerage currently has a market perform rating on the biotechnology company’s stock.Several other research analysts have also recently commented on the stock.HC Wainwright reaffirmed a buy rating and […]The Olympia Report